RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy

Detalles Bibliográficos
Autores principales: Ergenç, İlkay, Tarık Kani, Haluk, Karabacak, Murat, Cömert Özer, Elif, Mehdiyev, Shahin, Jafarov, Fuad, Yiğit Abacar, Kerem, Kutluğ Ağaçkıran, Seda, Sevik, Gizem, Aslan, Rahmi, Alibaz Öner, Fatma, İnanç, Nevsun, Pamir Atagündüz, Mehmet, Seçkin, Dilek, Özen Alahdab, Yeşim, Ergun, Tülin, Direskeneli, Haner, Atuğ, Özlen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Author’s Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152175/
https://www.ncbi.nlm.nih.gov/pubmed/36919837
http://dx.doi.org/10.5152/tjg.2023.237002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152175/
https://www.ncbi.nlm.nih.gov/pubmed/36919837
http://dx.doi.org/10.5152/tjg.2023.237002

Ejemplares similares